ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bispecific Antibody Technology Platform Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-15S15020
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bispecific Antibody Technology Platform Market Insights Forecast to 2029
BUY CHAPTERS

Global Bispecific Antibody Technology Platform Market Research Report 2025

Code: QYRE-Auto-15S15020
Report
January 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Roche
Wuxi Biologics
Merus NV
ALPHAMAB ONCOLOGY
Amgen Inc
ZymeWorks
Epimab
AbbVie
Lindis Biotech
Genmab
MacroGenics Inc
Adimab
Akeso, Inc.
YZY Biopharma

Bispecific Antibody Technology Platform Market

The global market for Bispecific Antibody Technology Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Bispecific Antibody Technology Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bispecific Antibody Technology Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Bispecific Antibody Technology Platform in Tumor Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bispecific Antibody Technology Platform include Sanofi, Roche, Abbvie, Amgen, Merus, Zymeworks, Lindis Biotech, Genmab, MacroGenics, Adimab, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Technology Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Technology Platform.
The Bispecific Antibody Technology Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bispecific Antibody Technology Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Technology Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bispecific Antibody Technology Platform Market Report

Report Metric Details
Report Name Bispecific Antibody Technology Platform Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Roche, Abbvie, Amgen, Merus, Zymeworks, Lindis Biotech, Genmab, MacroGenics, Adimab, Alphamab Oncology, EpimAb, Wuxi Biologics, Akeso, Inc, YZY Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bispecific Antibody Technology Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bispecific Antibody Technology Platform Market report?

Ans: The main players in the Bispecific Antibody Technology Platform Market are Sanofi, Roche, Abbvie, Amgen, Merus, Zymeworks, Lindis Biotech, Genmab, MacroGenics, Adimab, Alphamab Oncology, EpimAb, Wuxi Biologics, Akeso, Inc, YZY Biopharma

What are the Application segmentation covered in the Bispecific Antibody Technology Platform Market report?

Ans: The Applications covered in the Bispecific Antibody Technology Platform Market report are Tumor Disease, Hemophilia, Eye Disease, Other

What are the Type segmentation covered in the Bispecific Antibody Technology Platform Market report?

Ans: The Types covered in the Bispecific Antibody Technology Platform Market report are IgG-like Bispecific Antibody Platform, Non IgG-like Bispecific Antibody Platform

Recommended Reports

Antibody Therapeutics

Cancer & Immunotherapy

Immunodiagnostics & Biologics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Antibody Technology Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IgG-like Bispecific Antibody Platform
1.2.3 Non IgG-like Bispecific Antibody Platform
1.3 Market by Application
1.3.1 Global Bispecific Antibody Technology Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor Disease
1.3.3 Hemophilia
1.3.4 Eye Disease
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific Antibody Technology Platform Market Perspective (2020-2031)
2.2 Global Bispecific Antibody Technology Platform Growth Trends by Region
2.2.1 Global Bispecific Antibody Technology Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bispecific Antibody Technology Platform Historic Market Size by Region (2020-2025)
2.2.3 Bispecific Antibody Technology Platform Forecasted Market Size by Region (2026-2031)
2.3 Bispecific Antibody Technology Platform Market Dynamics
2.3.1 Bispecific Antibody Technology Platform Industry Trends
2.3.2 Bispecific Antibody Technology Platform Market Drivers
2.3.3 Bispecific Antibody Technology Platform Market Challenges
2.3.4 Bispecific Antibody Technology Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific Antibody Technology Platform Players by Revenue
3.1.1 Global Top Bispecific Antibody Technology Platform Players by Revenue (2020-2025)
3.1.2 Global Bispecific Antibody Technology Platform Revenue Market Share by Players (2020-2025)
3.2 Global Bispecific Antibody Technology Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bispecific Antibody Technology Platform Revenue
3.4 Global Bispecific Antibody Technology Platform Market Concentration Ratio
3.4.1 Global Bispecific Antibody Technology Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibody Technology Platform Revenue in 2024
3.5 Global Key Players of Bispecific Antibody Technology Platform Head office and Area Served
3.6 Global Key Players of Bispecific Antibody Technology Platform, Product and Application
3.7 Global Key Players of Bispecific Antibody Technology Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific Antibody Technology Platform Breakdown Data by Type
4.1 Global Bispecific Antibody Technology Platform Historic Market Size by Type (2020-2025)
4.2 Global Bispecific Antibody Technology Platform Forecasted Market Size by Type (2026-2031)
5 Bispecific Antibody Technology Platform Breakdown Data by Application
5.1 Global Bispecific Antibody Technology Platform Historic Market Size by Application (2020-2025)
5.2 Global Bispecific Antibody Technology Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bispecific Antibody Technology Platform Market Size (2020-2031)
6.2 North America Bispecific Antibody Technology Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bispecific Antibody Technology Platform Market Size by Country (2020-2025)
6.4 North America Bispecific Antibody Technology Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bispecific Antibody Technology Platform Market Size (2020-2031)
7.2 Europe Bispecific Antibody Technology Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bispecific Antibody Technology Platform Market Size by Country (2020-2025)
7.4 Europe Bispecific Antibody Technology Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific Antibody Technology Platform Market Size (2020-2031)
8.2 Asia-Pacific Bispecific Antibody Technology Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bispecific Antibody Technology Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Bispecific Antibody Technology Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bispecific Antibody Technology Platform Market Size (2020-2031)
9.2 Latin America Bispecific Antibody Technology Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bispecific Antibody Technology Platform Market Size by Country (2020-2025)
9.4 Latin America Bispecific Antibody Technology Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific Antibody Technology Platform Market Size (2020-2031)
10.2 Middle East & Africa Bispecific Antibody Technology Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bispecific Antibody Technology Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Bispecific Antibody Technology Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Bispecific Antibody Technology Platform Introduction
11.1.4 Sanofi Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Bispecific Antibody Technology Platform Introduction
11.2.4 Roche Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Abbvie
11.3.1 Abbvie Company Details
11.3.2 Abbvie Business Overview
11.3.3 Abbvie Bispecific Antibody Technology Platform Introduction
11.3.4 Abbvie Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.3.5 Abbvie Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Bispecific Antibody Technology Platform Introduction
11.4.4 Amgen Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 Merus
11.5.1 Merus Company Details
11.5.2 Merus Business Overview
11.5.3 Merus Bispecific Antibody Technology Platform Introduction
11.5.4 Merus Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.5.5 Merus Recent Development
11.6 Zymeworks
11.6.1 Zymeworks Company Details
11.6.2 Zymeworks Business Overview
11.6.3 Zymeworks Bispecific Antibody Technology Platform Introduction
11.6.4 Zymeworks Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.6.5 Zymeworks Recent Development
11.7 Lindis Biotech
11.7.1 Lindis Biotech Company Details
11.7.2 Lindis Biotech Business Overview
11.7.3 Lindis Biotech Bispecific Antibody Technology Platform Introduction
11.7.4 Lindis Biotech Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.7.5 Lindis Biotech Recent Development
11.8 Genmab
11.8.1 Genmab Company Details
11.8.2 Genmab Business Overview
11.8.3 Genmab Bispecific Antibody Technology Platform Introduction
11.8.4 Genmab Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.8.5 Genmab Recent Development
11.9 MacroGenics
11.9.1 MacroGenics Company Details
11.9.2 MacroGenics Business Overview
11.9.3 MacroGenics Bispecific Antibody Technology Platform Introduction
11.9.4 MacroGenics Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.9.5 MacroGenics Recent Development
11.10 Adimab
11.10.1 Adimab Company Details
11.10.2 Adimab Business Overview
11.10.3 Adimab Bispecific Antibody Technology Platform Introduction
11.10.4 Adimab Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.10.5 Adimab Recent Development
11.11 Alphamab Oncology
11.11.1 Alphamab Oncology Company Details
11.11.2 Alphamab Oncology Business Overview
11.11.3 Alphamab Oncology Bispecific Antibody Technology Platform Introduction
11.11.4 Alphamab Oncology Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.11.5 Alphamab Oncology Recent Development
11.12 EpimAb
11.12.1 EpimAb Company Details
11.12.2 EpimAb Business Overview
11.12.3 EpimAb Bispecific Antibody Technology Platform Introduction
11.12.4 EpimAb Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.12.5 EpimAb Recent Development
11.13 Wuxi Biologics
11.13.1 Wuxi Biologics Company Details
11.13.2 Wuxi Biologics Business Overview
11.13.3 Wuxi Biologics Bispecific Antibody Technology Platform Introduction
11.13.4 Wuxi Biologics Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.13.5 Wuxi Biologics Recent Development
11.14 Akeso, Inc
11.14.1 Akeso, Inc Company Details
11.14.2 Akeso, Inc Business Overview
11.14.3 Akeso, Inc Bispecific Antibody Technology Platform Introduction
11.14.4 Akeso, Inc Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.14.5 Akeso, Inc Recent Development
11.15 YZY Biopharma
11.15.1 YZY Biopharma Company Details
11.15.2 YZY Biopharma Business Overview
11.15.3 YZY Biopharma Bispecific Antibody Technology Platform Introduction
11.15.4 YZY Biopharma Revenue in Bispecific Antibody Technology Platform Business (2020-2025)
11.15.5 YZY Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Roche
Wuxi Biologics
Merus NV
ALPHAMAB ONCOLOGY
Amgen Inc
ZymeWorks
Epimab
AbbVie
Lindis Biotech
Genmab
MacroGenics Inc
Adimab
Akeso, Inc.
YZY Biopharma
List of Tables
 Table 1. Global Bispecific Antibody Technology Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of IgG-like Bispecific Antibody Platform
 Table 3. Key Players of Non IgG-like Bispecific Antibody Platform
 Table 4. Global Bispecific Antibody Technology Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Bispecific Antibody Technology Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Bispecific Antibody Technology Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Bispecific Antibody Technology Platform Market Share by Region (2020-2025)
 Table 8. Global Bispecific Antibody Technology Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Bispecific Antibody Technology Platform Market Share by Region (2026-2031)
 Table 10. Bispecific Antibody Technology Platform Market Trends
 Table 11. Bispecific Antibody Technology Platform Market Drivers
 Table 12. Bispecific Antibody Technology Platform Market Challenges
 Table 13. Bispecific Antibody Technology Platform Market Restraints
 Table 14. Global Bispecific Antibody Technology Platform Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Bispecific Antibody Technology Platform Market Share by Players (2020-2025)
 Table 16. Global Top Bispecific Antibody Technology Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Technology Platform as of 2024)
 Table 17. Ranking of Global Top Bispecific Antibody Technology Platform Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Bispecific Antibody Technology Platform Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Bispecific Antibody Technology Platform, Headquarters and Area Served
 Table 20. Global Key Players of Bispecific Antibody Technology Platform, Product and Application
 Table 21. Global Key Players of Bispecific Antibody Technology Platform, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Bispecific Antibody Technology Platform Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Bispecific Antibody Technology Platform Revenue Market Share by Type (2020-2025)
 Table 25. Global Bispecific Antibody Technology Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Bispecific Antibody Technology Platform Revenue Market Share by Type (2026-2031)
 Table 27. Global Bispecific Antibody Technology Platform Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Bispecific Antibody Technology Platform Revenue Market Share by Application (2020-2025)
 Table 29. Global Bispecific Antibody Technology Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Bispecific Antibody Technology Platform Revenue Market Share by Application (2026-2031)
 Table 31. North America Bispecific Antibody Technology Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Bispecific Antibody Technology Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Bispecific Antibody Technology Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Bispecific Antibody Technology Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Bispecific Antibody Technology Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Bispecific Antibody Technology Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Bispecific Antibody Technology Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Bispecific Antibody Technology Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Bispecific Antibody Technology Platform Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bispecific Antibody Technology Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Bispecific Antibody Technology Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Bispecific Antibody Technology Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Bispecific Antibody Technology Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Bispecific Antibody Technology Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Bispecific Antibody Technology Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Sanofi Company Details
 Table 47. Sanofi Business Overview
 Table 48. Sanofi Bispecific Antibody Technology Platform Product
 Table 49. Sanofi Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 50. Sanofi Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Bispecific Antibody Technology Platform Product
 Table 54. Roche Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Abbvie Company Details
 Table 57. Abbvie Business Overview
 Table 58. Abbvie Bispecific Antibody Technology Platform Product
 Table 59. Abbvie Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 60. Abbvie Recent Development
 Table 61. Amgen Company Details
 Table 62. Amgen Business Overview
 Table 63. Amgen Bispecific Antibody Technology Platform Product
 Table 64. Amgen Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 65. Amgen Recent Development
 Table 66. Merus Company Details
 Table 67. Merus Business Overview
 Table 68. Merus Bispecific Antibody Technology Platform Product
 Table 69. Merus Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 70. Merus Recent Development
 Table 71. Zymeworks Company Details
 Table 72. Zymeworks Business Overview
 Table 73. Zymeworks Bispecific Antibody Technology Platform Product
 Table 74. Zymeworks Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 75. Zymeworks Recent Development
 Table 76. Lindis Biotech Company Details
 Table 77. Lindis Biotech Business Overview
 Table 78. Lindis Biotech Bispecific Antibody Technology Platform Product
 Table 79. Lindis Biotech Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 80. Lindis Biotech Recent Development
 Table 81. Genmab Company Details
 Table 82. Genmab Business Overview
 Table 83. Genmab Bispecific Antibody Technology Platform Product
 Table 84. Genmab Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 85. Genmab Recent Development
 Table 86. MacroGenics Company Details
 Table 87. MacroGenics Business Overview
 Table 88. MacroGenics Bispecific Antibody Technology Platform Product
 Table 89. MacroGenics Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 90. MacroGenics Recent Development
 Table 91. Adimab Company Details
 Table 92. Adimab Business Overview
 Table 93. Adimab Bispecific Antibody Technology Platform Product
 Table 94. Adimab Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 95. Adimab Recent Development
 Table 96. Alphamab Oncology Company Details
 Table 97. Alphamab Oncology Business Overview
 Table 98. Alphamab Oncology Bispecific Antibody Technology Platform Product
 Table 99. Alphamab Oncology Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 100. Alphamab Oncology Recent Development
 Table 101. EpimAb Company Details
 Table 102. EpimAb Business Overview
 Table 103. EpimAb Bispecific Antibody Technology Platform Product
 Table 104. EpimAb Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 105. EpimAb Recent Development
 Table 106. Wuxi Biologics Company Details
 Table 107. Wuxi Biologics Business Overview
 Table 108. Wuxi Biologics Bispecific Antibody Technology Platform Product
 Table 109. Wuxi Biologics Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 110. Wuxi Biologics Recent Development
 Table 111. Akeso, Inc Company Details
 Table 112. Akeso, Inc Business Overview
 Table 113. Akeso, Inc Bispecific Antibody Technology Platform Product
 Table 114. Akeso, Inc Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 115. Akeso, Inc Recent Development
 Table 116. YZY Biopharma Company Details
 Table 117. YZY Biopharma Business Overview
 Table 118. YZY Biopharma Bispecific Antibody Technology Platform Product
 Table 119. YZY Biopharma Revenue in Bispecific Antibody Technology Platform Business (2020-2025) & (US$ Million)
 Table 120. YZY Biopharma Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Bispecific Antibody Technology Platform Picture
 Figure 2. Global Bispecific Antibody Technology Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bispecific Antibody Technology Platform Market Share by Type: 2024 VS 2031
 Figure 4. IgG-like Bispecific Antibody Platform Features
 Figure 5. Non IgG-like Bispecific Antibody Platform Features
 Figure 6. Global Bispecific Antibody Technology Platform Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bispecific Antibody Technology Platform Market Share by Application: 2024 VS 2031
 Figure 8. Tumor Disease Case Studies
 Figure 9. Hemophilia Case Studies
 Figure 10. Eye Disease Case Studies
 Figure 11. Other Case Studies
 Figure 12. Bispecific Antibody Technology Platform Report Years Considered
 Figure 13. Global Bispecific Antibody Technology Platform Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Bispecific Antibody Technology Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Bispecific Antibody Technology Platform Market Share by Region: 2024 VS 2031
 Figure 16. Global Bispecific Antibody Technology Platform Market Share by Players in 2024
 Figure 17. Global Top Bispecific Antibody Technology Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Technology Platform as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Bispecific Antibody Technology Platform Revenue in 2024
 Figure 19. North America Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Bispecific Antibody Technology Platform Market Share by Country (2020-2031)
 Figure 21. United States Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Bispecific Antibody Technology Platform Market Share by Country (2020-2031)
 Figure 25. Germany Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Bispecific Antibody Technology Platform Market Share by Region (2020-2031)
 Figure 33. China Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Bispecific Antibody Technology Platform Market Share by Country (2020-2031)
 Figure 41. Mexico Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Bispecific Antibody Technology Platform Market Share by Country (2020-2031)
 Figure 45. Turkey Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Bispecific Antibody Technology Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Sanofi Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 49. Roche Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 50. Abbvie Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 51. Amgen Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 52. Merus Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 53. Zymeworks Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 54. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 55. Genmab Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 56. MacroGenics Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 57. Adimab Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 58. Alphamab Oncology Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 59. EpimAb Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 60. Wuxi Biologics Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 61. Akeso, Inc Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 62. YZY Biopharma Revenue Growth Rate in Bispecific Antibody Technology Platform Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Bispecific Antibody Development Platform Market Research Report 2024
BiSpecific MAbS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Double Antibody Technology Platform Market Research Report 2025
Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD Targeted Bispecific Antibody Market Research Report 2024
Global Antibody Discovery Platforms Market Research Report 2025
Global ELISA Testing Platform Market Research Report 2024
Global Bispecific Antibodies Drug Market Research Report 2025
Global Single Domain Antibody Platforms Market Research Report 2024
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Bi Specific MAbS Market Research Report 2024
Global Next Generation Antibody Therapeutics Market Research Report 2025
Global Bispecific Antibody Molecular Drug Market Research Report 2025
Global Chimeric Antibody Market Research Report 2025
Global Antibodies Market Research Report 2024
Global Antibody Purification Kits Market Research Report 2025
Global Antibody Array Market Research Report 2025
Global Antibody Testing Market Research Report 2024
Global Flow Cytometry Antibody Products Market Research Report 2025

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions